Qube Research & Technologies »

Atyr Pharma shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Atyr Pharma (LIFE) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 9.6k 1.95
2023-09-30 $297 188 1.58
2021-12-31 $87k 12k 7.46

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Atyr Pharma

Federated Investors
FMR
Logos Global Management
Vanguard Group
Citadel Advisors
Woodline Partners
Alyeska Investment Group
Checkpoint Capital
BlackRock
Octagon Capital Advisors
Barclays
Geode Capital Management
Tang Capital Management
GSA Capital Partners
Goldman Sachs Group

View all funds holding Atyr Pharma